Text

Monitoring Efikasi Pengobatan Kombinasi Artesunate-Amodiaquine (AAQ) pada Penderita Malaria Plasmodium falciparum tanpa komplikasi di Sulawesi Tenggara

---

Malaria is one of the leading causes of mortality in risk populations such as infants, children, and pregnant women. Moreover, antimalarial drugs resistance, particularly Plasmodium falciparum malaria, has become a major problem in malaria control.

South-East Sulawesi is a malaria endemic area where about 28,205 and 32,040 cases of malaria were reported in 2010 and 2011, respectively. Artesunate-amodiaquine combination therapy (AAQ) has been used since 2004 as first-line treatment for uncomplicated P. falciparum malaria in South-East Sulawesi. Therefore, monitoring its therapeutic efficacy is essential to stopping the spread of ACT resistance. To monitor the therapeutic efficacy of AAQ in South-East Sulawesi, a single-arm prospective study was conducted. Subjects, who received AAQ, were followed-up for 28 days.

The results showed that the proportion of clinical and parasitological cure on day-28 without recrudescence was 100%. Moreover, no parasites were found on day-3 of follow-up.

Keywords: Malaria, Plasmodium falciparum, Artesunate Amodiaquine (AAQ), South-East Sulawesi

---

Availability

Detail Information

Series Title

-

Call Number

Aspirator, 6 (2) : 49-54

Publisher

Ciamis : Loka Litbang P2B2 Ciamis., 2014

Collation

6p

Language

ISBN/ISSN

2085-4102

Classification

-

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

malaria
plasmodium falciparum

Specific Detail Info

-

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment